Associate Director, Business Development and Strategy
METiS Therapeutics
Cambridge, Massachusetts, United States
Dr. Daniel Quevedo, PhD, is an Associate Director for Strategy and Business Development at METiS Therapeutics, which focuses on applying AI and ML tools to develop novel Lipid Nanoparticles with advanced extrahepatic targeting. Daniel obtained a Bachelor's degree in Biomedical Engineering from the University of Miami, was a Fulbright Grantee at the Karlsruher Institut für Technologie, and earned his PhD from the University of Michigan, where he conducted research in Joerg Lahann's lab. He was recently recognized as one of the University of Miami's 30 Under 30 Alumni.
Disclosure information not submitted.
Workshop The Application of AI to Drug Delivery and Controlled Release
Monday, July 8, 2024
8:00 AM – 12:00 PM CET
